Check Point Software Technologies Ltd | 114.2500 / +3.26% |
News
- ALX Oncology and Tallac Therapeutics Announce Collaboration on Novel Class of Cancer Immunotherapeutics
03/04/2021 / 22:05 - GlobeNewswire - Checkpoint Therapeutics to Participate in H.C. Wainwright Global Life Sciences Virtual Conference
03/04/2021 / 14:00 - GlobeNewswire - Replimune to Present at Three Upcoming Investor Conferences
03/04/2021 / 14:00 - GlobeNewswire - BioXcel Therapeutics to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call and Webcast
03/04/2021 / 13:00 - GlobeNewswire - Tempest Therapeutics Announces Clinical Collaboration with Roche to Advance TPST-1120 into a Randomized Combination Study in First-line Hepatocellular Carcinoma
03/03/2021 / 14:00 - GlobeNewswire - Purple Biotech Appoints Biopharmaceutical Industry Veteran Robert Gagnon to Board of Directors
03/03/2021 / 13:00 - GlobeNewswire - Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma
03/03/2021 / 12:45 - GlobeNewswire - Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma
03/03/2021 / 12:45 - GlobeNewswire - Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2020 Financial Report
03/02/2021 / 14:30 - GlobeNewswire - Indeni Joins GitLab Partner Program With Cloud Security Analysis Tool Cloudrail
03/02/2021 / 14:00 - GlobeNewswire - Purple Biotech Provides Corporate Update and Reports Second Half and Full Year 2020 Financial Results
03/02/2021 / 13:00 - GlobeNewswire - ALX Oncology to Participate at H.C. Wainwright Global Life Sciences Conference
03/02/2021 / 13:00 - GlobeNewswire - AzurRx BioPharma to Participate in “Fireside Chat” at the H.C. Wainwright Global Life Sciences Conference
03/02/2021 / 13:00 - GlobeNewswire - Highlight & Pivotal start Phase IIa melanoma trial
03/02/2021 / 12:55 - GlobeNewswire - ChemoCentryx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
03/01/2021 / 22:05 - GlobeNewswire